Statin Comparative Studies Needed, Oregon Drug Effectiveness Review Project Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
DERP wants comparative-effectiveness study on LDL-c lowering capabilities and adverse events.
You may also be interested in...
Medco Savings Tool Spotlights Consumer Reports’ “Best Buy” Drugs
PBM will feature link to Consumer Reports Best Buy Drugs for certain medication classes.
AstraZeneca’s Crestor Targets High Risk Patients, Delivers High Sales
Crestor sales grew 47% in the second quarter; entry of generic simvastatin caused some expected “disruption” in the marketplace.
Lipitor Is Pound-Wise Versus Generic Zocor, Pfizer IDEAL Cost Study Says
When total healthcare costs are considered, atorvastatin is more cost-effective than simvastatin even when Zocor is discounted 50% from its current price, Pfizer analysis says.